High flow oxygen therapy delivers breathing gas through a simple, loose-fitting nasal cannula that is more comfortable for the baby. It can provide on-going respiratory support throughout the infant’s recovery process.
High flow oxygen therapy is available as an optional upgrade on the SLE6000, enabling neonatal staff to provide more comprehensive care.
High Flow Oxygen Therapy References:
“The objective was to assess frequency of use, safety and clinical utility and to compare outcomes of premature infants on Nasal CPAP. This was done on two tertiary care centres. HHFNC has increased in the past few years. Reasons for this increase include ease of uses, infants appear to tolerate the system well, appears to be minimal nasal trauma compared to nasal CPAP. Clinically outcomes, anecdotally, appear to be at least similar to nasal CPAP. “
Authors: MT Shoemaker, MR Pierce, B Yoder, RJ Di Geronimo; Article: High Flow Nasal Cannula versus nasal CPAP for neonatal respiratory disease: a retrospective study; Publication: Journal of Perinatology (2007)
“The mechanisms of High Flow Therapy are fivefold; 1. Flushes the dead space of the nasopharyngeal cavity allowing for better ventilation and oxygenation … 2. Provides a flow adequate to support inspiration therefore reducing WOB … 3. Improves lung and airway mechanics by eliminating the effects of drying and cooling … 4. Reduces or eliminates the metabolic cost of gas conditioning … 5. Can be used to provide distending pressure.”
Authors: Kevin Dysart, Thomas Schaffer, Thomas L Miller, Maria R Wolfson; Article: Research in High Flow Therapy: Mechanisms of action; Publication: Respiratory Medicine 2009